GlassScriptPhysician profile
Blaz Podgorsek
NPI 1922678556
$2,783.13
in general payments reported to CMS, 2019-2025
11 companies · $704 in 2025
The $704 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,308 · 2024: $772 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,783.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $917.73 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $435.07 | 2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention, Enroute Transcarotid Stent |
| Inari Medical, INC. | $433.37 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $237.52 | 2025 | Perclot, Preveleak |
| Bolton Medical INC | $173.55 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Atricure, INC. | $167.58 | 2024 | |
| Abiomed | $152.04 | 2023 | Impella |
| Dilon Technologies, INC. | $137.79 | 2023 | Hemoblast Bellows |
| Angiodynamics, INC. | $70.97 | 2024 | Alphavac |
| Stryker Corporation | $31.13 | 2025 | Clottriever Bold Catheter |
| Ethicon US, LLC | $26.38 | 2024 | Stratafix, Harmonic, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaz Podgorsek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.